Examining Persistence for Ibrance (palbociclib) for FDA Approved indication and dosing through a retrospective analysis
Affiliation
College of Pharmacy, The University of ArizonaIssue Date
2019Keywords
IbrancePalbociclib
FDA Approved
Retrospective Analysis
Metastatic Breast Cancer
Letrozole
Fulvestrant
Medication Adherence
Therapy
MeSH Subjects
Breast NeoplasmsUnited States Food and Drug Administration
Letrozole
Fulvestrant
Medication Adherence
Advisor
Mathews, KellyGianninoto, Jenna
Slack, Marion